• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗前晚期动态对比增强磁共振成像可预测局部晚期宫颈癌的预后。

Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.

作者信息

Lund Kjersti V, Simonsen Trude G, Kristensen Gunnar B, Rofstad Einar K

机构信息

a Department of Radiation Biology , Institute for Cancer Research, Norwegian Radium Hospital , Oslo , Norway.

b Department of Radiology and Nuclear Medicine , Oslo University Hospital , Oslo , Norway.

出版信息

Acta Oncol. 2017 May;56(5):675-681. doi: 10.1080/0284186X.2017.1294762. Epub 2017 Feb 28.

DOI:10.1080/0284186X.2017.1294762
PMID:28447564
Abstract

BACKGROUND

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) may provide prognostic biomarkers for cervix carcinoma. We have shown previously that the early phase of the signal intensity-versus-time curve (SITC) may have significant prognostic power. The purpose of the present investigation was to explore the prognostic value of the late phase of the SITC.

MATERIAL AND METHODS

DCE-MRI data of 80 patients (FIGO stage IB-IVA) treated with concurrent chemoradiotherapy were examined. Four parameters were calculated from the late-phase SITC: tumor volume with decreasing signal, tumor fraction with decreasing signal, tumor volume with increasing signal (TVIS), and tumor fraction with increasing signal.

RESULTS

Multivariate analysis involving clinical parameters and late-phase SITC parameters suggested that TVIS is a strong independent prognostic factor for both disease-free and overall survival. When early-phase SITC parameters were included in the multivariate analysis, the early-phase SITC, but not the late-phase SITC, was found to have independent prognostic value.

CONCLUSION

The late-phase SITC can provide prognostic factors for the outcome of cervix carcinoma, that is, a large tumor volume with increasing late-phase SITCs is associated with poor outcome. However, the prognostic power of the late-phase SITC is not as strong as that of the early-phase SITC.

摘要

背景

动态对比增强磁共振成像(DCE-MRI)可为宫颈癌提供预后生物标志物。我们之前已经表明,信号强度-时间曲线(SITC)的早期阶段可能具有显著的预后价值。本研究的目的是探讨SITC晚期阶段的预后价值。

材料与方法

对80例接受同步放化疗的患者(国际妇产科联盟(FIGO)分期为IB-IVA期)的DCE-MRI数据进行了检查。从SITC晚期阶段计算出四个参数:信号降低的肿瘤体积、信号降低的肿瘤比例、信号增加的肿瘤体积(TVIS)以及信号增加的肿瘤比例。

结果

涉及临床参数和SITC晚期阶段参数的多因素分析表明,TVIS是无病生存期和总生存期的一个强大的独立预后因素。当将SITC早期阶段参数纳入多因素分析时,发现SITC早期阶段而非晚期阶段具有独立预后价值。

结论

SITC晚期阶段可为宫颈癌的预后提供因素,即晚期SITC信号增加且肿瘤体积较大与预后不良相关。然而,SITC晚期阶段的预后能力不如早期阶段强。

相似文献

1
Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.治疗前晚期动态对比增强磁共振成像可预测局部晚期宫颈癌的预后。
Acta Oncol. 2017 May;56(5):675-681. doi: 10.1080/0284186X.2017.1294762. Epub 2017 Feb 28.
2
Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.基于 Brix 模型的局部晚期宫颈癌 DCE-MRI 药代动力学分析。
Acta Oncol. 2019 Jun;58(6):828-837. doi: 10.1080/0284186X.2019.1580386. Epub 2019 Feb 27.
3
DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.局部晚期宫颈癌的 DCE-MRI:Tofts 分析与非模型分析的比较。
Radiat Oncol. 2020 Apr 15;15(1):79. doi: 10.1186/s13014-020-01526-2.
4
Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.短期预处理动态对比增强磁共振成像在预测局部晚期宫颈癌预后中的应用
Radiother Oncol. 2015 Jun;115(3):379-85. doi: 10.1016/j.radonc.2015.05.001. Epub 2015 May 18.
5
Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.动态对比增强磁共振成像在宫颈癌中的应用:对比增强时间百分比筛选可识别预测放化疗抵抗的参数。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e485-92. doi: 10.1016/j.ijrobp.2011.05.050. Epub 2011 Oct 17.
6
DCE-MRI-Derived Measures of Tumor Hypoxia and Interstitial Fluid Pressure Predict Outcomes in Cervical Carcinoma.DCE-MRI 衍生的肿瘤乏氧和间质液压力测量预测宫颈癌结局。
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1193-1201. doi: 10.1016/j.ijrobp.2018.04.035. Epub 2018 Apr 19.
7
Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.基于动态对比增强 CT 和 DCE 磁共振成像的局部晚期宫颈癌灌注参数的体素比较。
Acta Oncol. 2013 Oct;52(7):1360-8. doi: 10.3109/0284186X.2013.813637. Epub 2013 Sep 5.
8
Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma.肿瘤周围间质液流速可预测宫颈癌患者的生存率。
Radiother Oncol. 2014 Oct;113(1):132-8. doi: 10.1016/j.radonc.2014.09.011. Epub 2014 Oct 15.
9
Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.根治性放化疗期间的磁共振成像可预测局部晚期宫颈癌的肿瘤复发和患者生存:KROG 16-01 的多机构回顾性分析。
Gynecol Oncol. 2017 Nov;147(2):334-339. doi: 10.1016/j.ygyno.2017.08.029. Epub 2017 Sep 19.
10
Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.从宫颈癌动态对比增强 MRI 得出的药代动力学参数可预测放化疗结果。
Radiother Oncol. 2013 Apr;107(1):117-22. doi: 10.1016/j.radonc.2012.11.007. Epub 2013 Jan 17.

引用本文的文献

1
The Utility of Contrast-Enhanced Magnetic Resonance Imaging in Uterine Cervical Cancer: A Systematic Review.对比增强磁共振成像在子宫颈癌中的应用:一项系统评价
Life (Basel). 2023 Jun 12;13(6):1368. doi: 10.3390/life13061368.
2
Identification of Tumor-Specific MRI Biomarkers Using Machine Learning (ML).使用机器学习(ML)识别肿瘤特异性MRI生物标志物。
Diagnostics (Basel). 2021 Apr 21;11(5):742. doi: 10.3390/diagnostics11050742.
3
DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
局部晚期宫颈癌的 DCE-MRI:Tofts 分析与非模型分析的比较。
Radiat Oncol. 2020 Apr 15;15(1):79. doi: 10.1186/s13014-020-01526-2.
4
Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR).经验证的影像生物标志物作为临床试验和常规实践中的决策工具:欧洲放射学会(ESR)EIBALL* 小组委员会的现状与建议
Insights Imaging. 2019 Aug 29;10(1):87. doi: 10.1186/s13244-019-0764-0.